The Editor’s Roundtable: Concurrent Hypertension and Dyslipidemia - 16/08/11
Doi : 10.1016/j.amjcard.2006.10.001
Vincent E. Friedewald, MD a, ⁎ 
, Peter H. Jones, MD b, Norman M. Kaplan, MD c, James L. Pool, MD d, William C. Roberts, MD e
, Peter H. Jones, MD b, Norman M. Kaplan, MD c, James L. Pool, MD d, William C. Roberts, MD e a Clinical Professor of Internal Medicine, University of Texas Health Sciences Center at Houston, Houston, Texas; Visiting Professor, University of Notre Dame, Notre Dame, Indiana
b Associate Professor of Medicine, Baylor College of Medicine, Houston, Texas
c Clinical Professor, Department of Internal Medicine, The University of Texas Southwestern Medical School, Dallas, Texas
d Professor of Medicine and Pharmacology, Baylor College of Medicine, Houston, Texas
e Editor-in-Chief, American Journal of Cardiology; Director, Baylor Heart and Vascular Institute, Baylor University Medical Center; Dean, A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System, Dallas, Texas
Corresponding author: Tel: 512-264-1611; fax: 512-264-7034.
Le texte complet de cet article est disponible en PDF.
Plan
| The manuscript is based on a meeting of the authors on March 17, 2006. |
© 2007
Elsevier Inc. Tous droits réservés.
Vol 99 - N° 1
P. 134-144 - janvier 2007 Retour au numéro
Article précédent
- Mitral Valve Prolapse: Now You See It; Now You Don’t: Recalling the Discovery, Rise and Decline of a Diagnosis
- Allen B. Weisse
- Omacor Effects on Serum Lipids and Clinical Outcome
- Matthew K. Ito, Joel Marrs, Craig Williams
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?